Stephen G Worthley
Overview
Explore the profile of Stephen G Worthley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
158
Citations
2558
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Peverill W, Incani A, Worthley S, Singbal Y, Garrahy P, McCann A, et al.
Int J Cardiol Heart Vasc
. 2020 Oct;
30:100643.
PMID: 33015315
Background: The present study is a prospective observational single arm clinical investigation, with parallel bench test interrogation, aimed at investigating the technical feasibility, safety and clinical outcomes with the cone...
12.
Windecker S, Latib A, Kedhi E, Kirtane A, Kandzari D, Mehran R, et al.
N Engl J Med
. 2020 Feb;
382(13):1208-1218.
PMID: 32050061
Background: Polymer-free drug-coated stents provide superior clinical outcomes to bare-metal stents in patients at high bleeding risk who undergo percutaneous coronary intervention (PCI) and are treated with 1 month of...
13.
Haude M, Lee S, Worthley S, Silber S, Verheye S, Rosli M, et al.
Catheter Cardiovasc Interv
. 2019 Sep;
95(6):1076-1084.
PMID: 31489742
Objectives: To evaluate the long-term safety and efficacy of the novel combined sirolimus-eluting endothelial progenitor cell capture Combo stent (OrbusNeich, Fort Lauderdale, FL) at 5 years in the REMEDEE (Randomized...
14.
Nelson A, Puri R, Nicholls S, Dundon B, Richardson J, Sidharta S, et al.
Am J Physiol Heart Circ Physiol
. 2019 Aug;
317(4):H811-H819.
PMID: 31441693
A large body of evidence demonstrates an independent association between arterial stiffness and prospective risk of cardiovascular events. A reduction in coronary perfusion is presumed to underscore this association; however,...
15.
Nelson A, Dundon B, Worthley S, Richardson J, Puri R, Wong D, et al.
Coron Artery Dis
. 2019 Mar;
30(7):520-527.
PMID: 30883431
Background: Cardiovascular disease is the leading cause of death in patients with chronic kidney disease. Studies investigating the disproportionate burden of cardiovascular disease have occurred predominantly in the peripheral vasculature,...
16.
Shishikura D, Kataoka Y, Pisaniello A, Delacroix S, Montarello J, Nicholls S, et al.
Circ Cardiovasc Interv
. 2018 Oct;
11(8):e006367.
PMID: 30354779
Background: Acute kidney injury (AKI) can be a major complication of transcatheter aortic valve replacement (TAVR). Atheroembolization of debris during catheter manipulation has been considered as a potential factor causing...
17.
Kataoka Y, Delacroix S, Sidharta S, Andrews J, Nicholls S, Tsioufis C, et al.
Int J Nephrol Renovasc Dis
. 2018 Oct;
11:259-266.
PMID: 30310302
Aim: Radiofrequency ablation of peri-arterial renal autonomic nerves has been studied as a potential therapeutic option for resistant hypertension. While recent clinical trials have reported its efficacy, there is paucity...
18.
Gooley R, Worthley S, Whitbourn R, Montarello J, Newcomb A, Allocco D, et al.
EuroIntervention
. 2018 Sep;
14(11):e1180-e1182.
PMID: 30248021
No abstract available.
19.
Nelson A, Montarello N, Cosgrove C, Roberts-Thomson R, Delacroix S, Chokka R, et al.
Med J Aust
. 2018 Aug;
209(3):136-141.
PMID: 30071816
Aortic stenosis is the most common valvular lesion requiring intervention and with an ageing population, its burden is likely to increase. Increasing comorbidity and a desire for less invasive treatment...
20.
Nicholls S, Andrews J, Kastelein J, Merkely B, Nissen S, Ray K, et al.
JAMA Cardiol
. 2018 Jul;
3(9):815-822.
PMID: 30046828
Importance: CER-001 is a negatively charged, engineered pre-β high-density lipoprotein (HDL) mimetic containing apolipoprotein A-I and sphingomyelin. Preliminary studies demonstrated favorable effects of CER-001 on cholesterol efflux and vascular inflammation....